CinCor Pharma, Inc.
CinCor Pharma, Inc. (CINC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CINC · as of Dec 31, 2022
Ownership Breakdown
113
Institutional Holders
▲ 24 vs Q3
$460.67M
Total Inst. Value
▼ $762.58M vs Q3
43.76M
Shares Outstanding
freeFloat 40.92%
37.42M
13F Shares Held
▲ 136,480 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CINC largest shareholders · institutional ownership
Q4 2022 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SOFINNOVA INVESTMENTS, INC. pharmaceutical preparations | 6.07M | 14.88% | 14.88% | $74.65B | Feb 14, 2023 | ▼ 6.0K |
5AM VENTURE MANAGEMENT, LLC pharmaceutical preparations | 4.94M | 12.10% | 12.10% | $60.68B | Feb 14, 2023 | — held |
GENERAL ATLANTIC, L.P. pharmaceutical preparations | 4.21M | 10.32% | 10.32% | $51.73B | Feb 14, 2023 | — held |
PERCEPTIVE ADVISORS LLC pharmaceutical preparations | 2.58M | 6.31% | 6.31% | $31.66B | Feb 14, 2023 | ▼ 730.3K |
ADAGE CAPITAL PARTNERS GP, L.L.C. pharmaceutical preparations | 1.99M | 4.89% | 4.89% | $24.51B | Feb 14, 2023 | ▼ 1.03M |
ORBIMED ADVISORS LLC pharmaceutical preparations | 1.91M | 4.67% | 4.67% | $23.42B | Feb 14, 2023 | ▲ 1.59M |
BLACKROCK INC. pharmaceutical preparations | 1.78M | 4.37% | 4.37% | $21.92B | Feb 13, 2023 | ▲ 464.4K |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 1.42M | 3.49% | 3.49% | $17.49B | Feb 14, 2023 | ▲ 145.7K |
RTW INVESTMENTS, LP pharmaceutical preparations | 1.39M | 3.41% | 3.41% | $17.08B | Feb 14, 2023 | — held |
ROCK SPRINGS CAPITAL MANAGEMENT LP pharmaceutical preparations | 1.12M | 2.74% | 2.74% | $13.72B | Feb 14, 2023 | ▼ 89.3K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2022 vs prior quarter
Q4 2022
19
Increased
+4.26M shares14
New Positions
first time holders11
Decreased
−3.83M shares0
Sold Out
fully exitedNet shares change (top 50)
+430.0K
+4.26M / −3.83M
Net new holders
+22
14 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CINC insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
6
Buy transactions
33
Sell transactions
0.18
Buy/Sell ratio
$9M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
5AM Partners VI, LLC 10 percent owner | Feb 24, 2023 | U-Tender | 496,323 | $26.00 | $12.90M | 0 | Form 4 ↗ |
HEALY JAMES
| Feb 24, 2023 | U-Tender | 9,803 | $26.00 | $254.9K | 19.6K | Form 4 ↗ |
HEALY JAMES
| Feb 24, 2023 | D-Return | 19,608 | — | — | 0 | Form 4 ↗ |
HEALY JAMES
| Nov 28, 2022 | Sale | 6,000 | $14.32 | $85.9K | 0 | Form 4 ↗ |
HEALY JAMES
| Feb 24, 2023 | U-Tender | 6,073,949 | $26.00 | $157.92M | 0 | Form 4 ↗ |
Freeman Mason Chief Medical Officer | Feb 24, 2023 | U-Tender | 2,494 | $26.00 | $64.8K | 40.0K | Form 4 ↗ |
Freeman Mason Chief Medical Officer | Jun 10, 2022 | Sale | 6 | $15.21 | $91.26 | 2.5K | Form 4 ↗ |
Freeman Mason Chief Medical Officer | Feb 24, 2023 | U-Tender | 100 | $26.00 | $2.6K | 0 | Form 4 ↗ |
Freeman Mason Chief Medical Officer | Feb 24, 2023 | D-Return | 40,000 | — | — | 0 | Form 4 ↗ |
Freeman Mason Chief Medical Officer | Feb 24, 2023 | D-Return | 30,178 | $0.92 | $27.8K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CinCor Pharma, Inc. (CINC) is primarily owned by institutional investors, who hold approximately 85.5% of total shares outstanding. Company insiders own approximately 59.08%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of CinCor Pharma, Inc. is SOFINNOVA INVESTMENTS, INC., holding approximately 6.07 million shares — equal to 14.88% of outstanding shares — as of December 31, 2022.
A total of 113 institutional investors currently hold CINC stock, with a combined institutional value of approximately $460,668,916 as of the most recent 13F filing period.
Frequently asked questions
CINC ownershipCinCor Pharma, Inc. (CINC) is primarily owned by institutional investors, who hold approximately 85.5% of shares. The largest shareholder is SOFINNOVA INVESTMENTS, INC. with a 14.88% stake. Company insiders hold 59.08%. Data sourced from SEC Form 13F as of December 31, 2022.